Login
Israel-Hamas Conflict
Juneteenth
Donald Trump
Artificial Intelligence
Social Media
World Cup
War
Senate
Republican Party
Immigration
Natural Disasters
Real Madrid
Democratic Party
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Telix image

News from Telix

If you want to know if Telix is credible or reliable, look no further. We rank Telix as Unknown factuality. Find out more about our methodology here.

Information about Telix

Where is Telix located?Telix's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Telix News

PSMA-PET Imaging Product, Gozellix, Launches on US Market
United States · United States

PSMA-PET Imaging Product, Gozellix, Launches on US Market

Gozellix was approved by the FDA in March 2025.See the Story

ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa

Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.Maryland · MarylandSee the Story

Telix to Host Investor Day in New York City on June 11, 2025

Melbourne (Australia) and Indianapolis, IN (U.S.) | 22 May 2025 Telix today announces it will host an Investor Day on Wednesday, June 11, 2025, in person, in New York City, from 8:30am to 12.30pm ET. Institutional investors, analysts and company guests are cordially invited to attend the session, which will focus on the growth opportunities across Telix’s commercial and clinical portfolio of precision medicine and therapeutic radiopharmaceutic…New York State · New YorkRead Article

Telix at ANZSNM Annual Scientific Meeting 2025

MELBOURNE, Australia, May 20, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces a strong presence at the 55th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM ASM 2025), to be held in Melbourne, Australia from 23–25 May 2025. Telix will feature prominently in the scientific program with eight oral and three poster presentations highlig…Melbourne, Australia · MelbourneSee the Story

Merkley introducing bill to lower prescription drug costs following Trump order

Coverage: 29 sources
PORTLAND, Ore. (KOIN) – Oregon Senator Jeff Merkley is teaming up with three congressional colleagues to introduce a bill aiming to slash prescription drug prices. Merkley is joined by Sen. Peter Welch (D-VT), Sen. Bernie Sanders (I-VT) and Congresswoman Debbie Dingell (D-MI) to introduce the End Price Gouging for Medications Act, the lawmakers announced Wednesday. According to the lawmakers, the bill would lower prescription drug costs for all …Bernie Sanders · United StatesSee the Story

Illuccix China Phase 3 Study Completes Enrolment

MELBOURNE, Australia and INDIANAPOLIS, May 13, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the pivotal Phase 3 registration study of TLX591-CDx (Illuccix®, Kit for the preparation of 68Ga-PSMA-11) for prostate cancer imaging in Chinese patients has completed patient enrolment. The Phase 3 Illuccix China study[1] is a prospective, open-label, single-arm, multicenter study…China · ChinaSee the Story

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

MELBOURNE, Australia and INDIANAPOLIS, May 8, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been published in Thyroid, the official journal of the American Thyroid Association. The candidate demonstrated an encouraging safety profile and efficacy in aggressive, radioiodine-resistant (RAI-R) thyroid…Delhi, India · DelhiSee the Story

Telix’s Illuccix® PSMA-PET Imaging Agent Approved in the Czech Republic

Telix’s Illuccix® PSMA-PET Imaging Agent Approved in the Czech Republic New approval provides hospitals and clinics in the Czech Republic with access to a proven PSMA-PET imaging agent Melbourne (Australia) | 5 May 2025 Telix today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing authorization in the Czech Republic by the SÚKL[2] for the…Czechia · CzechiaRead Article

Illuccix Prostate Cancer PSMA-PET Imaging Agent Approved in Finland - PressReach

MELBOURNE, Australia, April 30, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing authorization by Fimea[2] for the detection and localization of prostate-specific membrane antigen (PSMA)-positive lesions in adults with prostate cancer, a broad …Finland · FinlandSee the Story

Breaking News Topics Related to Telix

Melbourne, Australia

Melbourne, Australia

Tariffs

Tariffs

Victoria, Australia

Victoria, Australia

Australia

Australia

United States

United States

News
For You
SearchBlindspotLocal